glycosyltransferase assay
Recently Published Documents


TOTAL DOCUMENTS

15
(FIVE YEARS 1)

H-INDEX

8
(FIVE YEARS 0)

2021 ◽  
Vol 9 ◽  
Author(s):  
Matjaž Weiss ◽  
Elena M. Loi ◽  
Maša Sterle ◽  
Cyril Balsollier ◽  
Tihomir Tomašič ◽  
...  

O-GlcNAcylation is an important post-translational and metabolic process in cells that must be carefully regulated. O-GlcNAc transferase (OGT) is ubiquitously present in cells and is the only enzyme that catalyzes the transfer of O-GlcNAc to proteins. OGT is a promising target in various pathologies such as cancer, immune system diseases, or nervous impairment. In our previous work we identified the 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives as promising compounds by a fragment-based drug design approach. Herein, we report the extension of this first series with several new fragments. As the most potent fragment, we identified 3b with an IC50 value of 116.0 μM. If compared with the most potent inhibitor of the first series, F20 (IC50 = 117.6 μM), we can conclude that the new fragments did not improve OGT inhibition remarkably. Therefore, F20 was used as the basis for the design of a series of compounds with the elongation toward the O-GlcNAc binding pocket as the free carboxylate allows easy conjugation. Compound 6b with an IC50 value of 144.5 μM showed the most potent OGT inhibition among the elongated compounds, but it loses inhibition potency when compared to the UDP mimetic F20. We therefore assume that the binding of the compounds in the O-GlcNAc binding pocket is likely not crucial for OGT inhibition. Furthermore, evaluation of the compounds with two different assays revealed that some inhibitors most likely interfere with the commercially available UDP-Glo™ glycosyltransferase assay, leading to false positive results. This observation calls for caution, when evaluating UDP mimetic as OGT inhibitors with the UDP-Glo™ glycosyltransferase assay, as misinterpretations can occur.



2020 ◽  
Author(s):  
Xinjian Yin ◽  
Jiaxin Li ◽  
Senhua Chen ◽  
Yuping Wu ◽  
Zhigang She ◽  
...  

<a></a>Here, we report the development of a high-throughput “FP-Tag” OGT assay with bovine serum albumin as a low-cost and superior “FP-Tag”. With this assay, 2-methyleurotinone was identified as a <a></a><a>low </a>M-range OGT inhibitor. This type of assay with BSA as “FP-Tag” would find more applications with other glycosyltransferases.



2020 ◽  
Author(s):  
Xinjian Yin ◽  
Jiaxin Li ◽  
Senhua Chen ◽  
Yuping Wu ◽  
Zhigang She ◽  
...  

<a></a>Here, we report the development of a high-throughput “FP-Tag” OGT assay with bovine serum albumin as a low-cost and superior “FP-Tag”. With this assay, 2-methyleurotinone was identified as a <a></a><a>low </a>M-range OGT inhibitor. This type of assay with BSA as “FP-Tag” would find more applications with other glycosyltransferases.



2016 ◽  
Vol 14 (4) ◽  
pp. 240-251 ◽  
Author(s):  
Thomas Zielinski ◽  
Melvin Reichman ◽  
Preston S. Donover ◽  
Robert G. Lowery


2014 ◽  
Vol 22 (8) ◽  
pp. 2571-2575 ◽  
Author(s):  
Jihye Ryu ◽  
Min Sik Eom ◽  
Wooseok Ko ◽  
Min Su Han ◽  
Hyun Soo Lee


MedChemComm ◽  
2014 ◽  
Vol 5 (8) ◽  
pp. 1193-1201 ◽  
Author(s):  
Lauren Tedaldi ◽  
Andrew Evitt ◽  
Niina Göös ◽  
Jingqian Jiang ◽  
Gerd K. Wagner

An operationally simple, colorimetric assay protocol for the identification and evaluation of galactosyltransferase inhibitors is described.



2011 ◽  
Vol 418 (1) ◽  
pp. 85-88 ◽  
Author(s):  
Hyun Soo Lee ◽  
Jon S. Thorson


Glycobiology ◽  
2010 ◽  
Vol 21 (6) ◽  
pp. 727-733 ◽  
Author(s):  
Z. L. Wu ◽  
C. M. Ethen ◽  
B. Prather ◽  
M. Machacek ◽  
W. Jiang


2006 ◽  
Vol 45 (4) ◽  
pp. 665-668 ◽  
Author(s):  
Jirarut Wongkongkatep ◽  
Yoshifumi Miyahara ◽  
Akio Ojida ◽  
Itaru Hamachi


2006 ◽  
Vol 118 (4) ◽  
pp. 681-684 ◽  
Author(s):  
Jirarut Wongkongkatep ◽  
Yoshifumi Miyahara ◽  
Akio Ojida ◽  
Itaru Hamachi


Sign in / Sign up

Export Citation Format

Share Document